These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14987898)

  • 41. Global vaccine project gets a shot in the arm.
    Check E
    Nature; 2005 Jan; 433(7024):345. PubMed ID: 15674258
    [No Abstract]   [Full Text] [Related]  

  • 42. United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.
    Perdue ML; Bright RA
    Vaccine; 2011 Jul; 29 Suppl 1():A48-50. PubMed ID: 21684430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of vaccine financing on vaccinations delivered by health department clinics.
    Szilagyi PG; Humiston SG; Shone LP; Barth R; Kolasa MS; Rodewald LE
    Am J Public Health; 2000 May; 90(5):739-45. PubMed ID: 10800422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of hepatitis B virus vaccine.
    Chin J
    N Engl J Med; 1982 Sep; 307(11):678-9. PubMed ID: 6810171
    [No Abstract]   [Full Text] [Related]  

  • 45. Occupational exposure to hepatitis B virus. Analysis of indications for hepatitis B vaccine.
    Lohiya G; Lohiya S; Caires S; Reesal MR
    J Occup Med; 1984 Mar; 26(3):189-96. PubMed ID: 6232354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors affecting U.S. manufacturers' decisions to produce vaccines.
    Coleman MS; Sangrujee N; Zhou F; Chu S
    Health Aff (Millwood); 2005; 24(3):635-42. PubMed ID: 15886154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. India: 50 years after independence.
    Miller DD; Nayak AR
    Nat Biotechnol; 1997 Aug; 15(8):727-9. PubMed ID: 9255782
    [No Abstract]   [Full Text] [Related]  

  • 48. The global vaccine enterprise: a developing world perspective.
    Shin SI
    Nat Med; 1998 May; 4(5 Suppl):503-5. PubMed ID: 9585198
    [No Abstract]   [Full Text] [Related]  

  • 49. Financing of vaccines.
    Barton JH
    Lancet; 2000 Apr; 355(9211):1269-70. PubMed ID: 10770320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The costs and economics of modern vaccine development.
    Batson A
    Dev Biol (Basel); 2002; 110():15-24. PubMed ID: 12477302
    [No Abstract]   [Full Text] [Related]  

  • 51. The health of healthcare, Part II: patient healthcare has cancer.
    Waldman D
    J Med Pract Manage; 2013; 29(2):113-6. PubMed ID: 24236323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Financing vaccines: in search of solutions that work.
    Iglehart JK
    Health Aff (Millwood); 2005; 24(3):594-5. PubMed ID: 15886147
    [No Abstract]   [Full Text] [Related]  

  • 53. Cautious industry welcome for US flu vaccine plan.
    Kling J
    Nat Biotechnol; 2005 Dec; 23(12):1457-8. PubMed ID: 16333275
    [No Abstract]   [Full Text] [Related]  

  • 54. Drug discovery.
    Kennedy D
    Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaccine candidates for poor nations are going to waste.
    Kaslow DC; Black S; Bloom DE; Datla M; Salisbury D; Rappuoli R
    Nature; 2018 Dec; 564(7736):337-339. PubMed ID: 30560957
    [No Abstract]   [Full Text] [Related]  

  • 56. Financing vaccination of children and adolescents: National Vaccine Advisory Committee recommendations.
    National Vaccine Advisory Committee
    Pediatrics; 2009 Dec; 124 Suppl 5():S558-62. PubMed ID: 19948588
    [No Abstract]   [Full Text] [Related]  

  • 57. WHO targets measles and hepatitis B in Western Pacific.
    Benitez MA
    Lancet; 2003 Sep; 362(9389):1048. PubMed ID: 14526777
    [No Abstract]   [Full Text] [Related]  

  • 58. [Relationship between pharmaceutical industry and public health in vaccination].
    Gervasi G; Capanna A; Soncini R; Zaratti L; Franco E
    Ig Sanita Pubbl; 2015; 71(2):225-32. PubMed ID: 26057178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Universal hepatitis B vaccination: the economics of prevention.
    Krahn MD; Detsky AS
    CMAJ; 1992 Jan; 146(1):19-21. PubMed ID: 1530815
    [No Abstract]   [Full Text] [Related]  

  • 60. Improving access to vaccines through tiered pricing.
    Berkley S
    Lancet; 2014 Jun; 383(9936):2265-7. PubMed ID: 24636625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.